Tiger BufordYour Orthopedic Industry Expert (free today)

Building clinical evidence for a future exit

29 May 2026 · 0 min

Watch on YouTube

0:20

Medical device startups need clinical evidence to get reimbursement and create "future currency"—the valuation metric that acquirers like Stryker and Smith & Nephew use. Without it, your exit potential collapses.

like you need to have evidence. And it's for all of the above. I think you guys spoke about VAC, you talked about, you know, reimbursement for future exits, right? They refer to it as future currency. So if you don't have clinical evidence, you know, eventually it's going to be meaningless to a Stryker or a, you know, Smith Nephew when they— when the day comes where they're trying to acquire you.

More from Tiger

1:00:35

BoneChat #146 - Raising Capital, Protecting Equity, Dilution & Staying Lean

1w ago

58:35

BoneChat #145 - ASC Robots, Direct-to-Patient Marketing & Ortho Startup Reality

2w ago

57:20

BoneChat #144 - Defining the Standard of Care for Orthopedic Tissue Preservation & Restoration

4w ago

56:40

BoneChat #143 - AI-Driven MedTech Sales, Startup Traps, & Orthopedic Commercialization

1mo ago

1:20

Reverse Shoulder movement in the US

1mo ago

1:03:29

BoneChat #142 - Fastest-Growing Ortho Segments, Reverse Shoulder & Joint Preservation Rollups

1mo ago

59:10

BoneChat #141 - Disrupting Surgical Visualization: Single-Use 4K Scopes with Richard McKillop

1mo ago

57:56

BoneChat #140 - Transforming Knee Rehab, Patient Experience, and MedTech Go-to-Market

1mo ago

0:36

How to find early adopters in Ortho.

2mo ago

0:35

The Importance of Controlling Your Own Destiny in Deals

2mo ago

0:50

Red Flags in Business Partnerships

2mo ago

See all content